205 related articles for article (PubMed ID: 37169988)
1. Machine learning based on gadoxetic acid-enhanced MRI for differentiating atypical intrahepatic mass-forming cholangiocarcinoma from poorly differentiated hepatocellular carcinoma.
Chen X; Chen Y; Chen H; Zhu J; Huang R; Xie J; Zhang T; Xie A; Li Y
Abdom Radiol (NY); 2023 Aug; 48(8):2525-2536. PubMed ID: 37169988
[TBL] [Abstract][Full Text] [Related]
2. DCE-MRI based radiomics nomogram for preoperatively differentiating combined hepatocellular-cholangiocarcinoma from mass-forming intrahepatic cholangiocarcinoma.
Zhou Y; Zhou G; Zhang J; Xu C; Zhu F; Xu P
Eur Radiol; 2022 Jul; 32(7):5004-5015. PubMed ID: 35128572
[TBL] [Abstract][Full Text] [Related]
3. Radiomic analysis of Gd-EOB-DTPA-enhanced MRI predicts Ki-67 expression in hepatocellular carcinoma.
Fan Y; Yu Y; Wang X; Hu M; Hu C
BMC Med Imaging; 2021 Jun; 21(1):100. PubMed ID: 34130644
[TBL] [Abstract][Full Text] [Related]
4. Hepatocellular carcinoma pathologic grade prediction using radiomics and machine learning models of gadoxetic acid-enhanced MRI: a two-center study.
Han YE; Cho Y; Kim MJ; Park BJ; Sung DJ; Han NY; Sim KC; Park YS; Park BN
Abdom Radiol (NY); 2023 Jan; 48(1):244-256. PubMed ID: 36131163
[TBL] [Abstract][Full Text] [Related]
5. A radiomics-based biomarker for cytokeratin 19 status of hepatocellular carcinoma with gadoxetic acid-enhanced MRI.
Wang W; Gu D; Wei J; Ding Y; Yang L; Zhu K; Luo R; Rao SX; Tian J; Zeng M
Eur Radiol; 2020 May; 30(5):3004-3014. PubMed ID: 32002645
[TBL] [Abstract][Full Text] [Related]
6. Radiomics model based on preoperative gadoxetic acid-enhanced MRI for predicting liver failure.
Zhu WS; Shi SY; Yang ZH; Song C; Shen J
World J Gastroenterol; 2020 Mar; 26(11):1208-1220. PubMed ID: 32231424
[TBL] [Abstract][Full Text] [Related]
7. Gd-EOB-DTPA-enhanced MRI radiomics to predict vessels encapsulating tumor clusters (VETC) and patient prognosis in hepatocellular carcinoma.
Yu Y; Fan Y; Wang X; Zhu M; Hu M; Shi C; Hu C
Eur Radiol; 2022 Feb; 32(2):959-970. PubMed ID: 34480625
[TBL] [Abstract][Full Text] [Related]
8. Preoperative Evaluation of Gd-EOB-DTPA-Enhanced MRI Radiomics-Based Nomogram in Small Solitary Hepatocellular Carcinoma (≤3 cm) With Microvascular Invasion: A Two-Center Study.
Tian Y; Hua H; Peng Q; Zhang Z; Wang X; Han J; Ma W; Chen J
J Magn Reson Imaging; 2022 Nov; 56(5):1459-1472. PubMed ID: 35298849
[TBL] [Abstract][Full Text] [Related]
9. Hepatocellular carcinoma: radiomics nomogram on gadoxetic acid-enhanced MR imaging for early postoperative recurrence prediction.
Zhang Z; Jiang H; Chen J; Wei Y; Cao L; Ye Z; Li X; Ma L; Song B
Cancer Imaging; 2019 May; 19(1):22. PubMed ID: 31088553
[TBL] [Abstract][Full Text] [Related]
10. Optimizing CT and MRI criteria for differentiating intrahepatic mass-forming cholangiocarcinoma and hepatocellular carcinoma.
Wu H; Liang Y; Wang Z; Tan C; Yang R; Wei X; Jiang X
Acta Radiol; 2023 Mar; 64(3):926-935. PubMed ID: 35898164
[TBL] [Abstract][Full Text] [Related]
11. Radiomics nomogram for prediction of glypican-3 positive hepatocellular carcinoma based on hepatobiliary phase imaging.
Zhang N; Wu M; Zhou Y; Yu C; Shi D; Wang C; Gao M; Lv Y; Zhu S
Front Oncol; 2023; 13():1209814. PubMed ID: 37841420
[TBL] [Abstract][Full Text] [Related]
12. Radiomics and nomogram of magnetic resonance imaging for preoperative prediction of microvascular invasion in small hepatocellular carcinoma.
Chen YD; Zhang L; Zhou ZP; Lin B; Jiang ZJ; Tang C; Dang YW; Xia YW; Song B; Long LL
World J Gastroenterol; 2022 Aug; 28(31):4399-4416. PubMed ID: 36159011
[TBL] [Abstract][Full Text] [Related]
13. MRI-based radiomics signature: a potential imaging biomarker for prediction of microvascular invasion in combined hepatocellular-cholangiocarcinoma.
Zhou G; Zhou Y; Xu X; Zhang J; Xu C; Xu P; Zhu F
Abdom Radiol (NY); 2024 Jan; 49(1):49-59. PubMed ID: 37831165
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance radiomics signatures for predicting poorly differentiated hepatocellular carcinoma: A SQUIRE-compliant study.
Yang X; Yuan C; Zhang Y; Wang Z
Medicine (Baltimore); 2021 May; 100(19):e25838. PubMed ID: 34106622
[TBL] [Abstract][Full Text] [Related]
15. Machine learning-based radiomics analysis of preoperative functional liver reserve with MRI and CT image.
Zhu L; Wang F; Chen X; Dong Q; Xia N; Chen J; Li Z; Zhu C
BMC Med Imaging; 2023 Jul; 23(1):94. PubMed ID: 37460944
[TBL] [Abstract][Full Text] [Related]
16. Differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma on gadoxetic acid-enhanced liver MR imaging.
Kim R; Lee JM; Shin CI; Lee ES; Yoon JH; Joo I; Kim SH; Hwang I; Han JK; Choi BI
Eur Radiol; 2016 Jun; 26(6):1808-17. PubMed ID: 26373763
[TBL] [Abstract][Full Text] [Related]
17. Can machine learning radiomics provide pre-operative differentiation of combined hepatocellular cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma to inform optimal treatment planning?
Liu X; Khalvati F; Namdar K; Fischer S; Lewis S; Taouli B; Haider MA; Jhaveri KS
Eur Radiol; 2021 Jan; 31(1):244-255. PubMed ID: 32749585
[TBL] [Abstract][Full Text] [Related]
18. Preoperative prediction of microvascular invasion in hepatocellular cancer: a radiomics model using Gd-EOB-DTPA-enhanced MRI.
Feng ST; Jia Y; Liao B; Huang B; Zhou Q; Li X; Wei K; Chen L; Li B; Wang W; Chen S; He X; Wang H; Peng S; Chen ZB; Tang M; Chen Z; Hou Y; Peng Z; Kuang M
Eur Radiol; 2019 Sep; 29(9):4648-4659. PubMed ID: 30689032
[TBL] [Abstract][Full Text] [Related]
19. Radiomics signature on dynamic contrast-enhanced MR images: a potential imaging biomarker for prediction of microvascular invasion in mass-forming intrahepatic cholangiocarcinoma.
Zhou Y; Zhou G; Zhang J; Xu C; Wang X; Xu P
Eur Radiol; 2021 Sep; 31(9):6846-6855. PubMed ID: 33638019
[TBL] [Abstract][Full Text] [Related]
20. Comparison of non-radiomics imaging features and radiomics models based on contrast-enhanced ultrasound and Gd-EOB-DTPA-enhanced MRI for predicting microvascular invasion in hepatocellular carcinoma within 5 cm.
Zheng R; Zhang X; Liu B; Zhang Y; Shen H; Xie X; Li S; Huang G
Eur Radiol; 2023 Sep; 33(9):6462-6472. PubMed ID: 37338553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
